Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR in Acute Schizophrenia
NCT00085891Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in schizophrenia, sponsored by AstraZeneca. Started Jun 2004; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00085891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085891.